About Acrivon Therapeutics, Inc. 
Acrivon Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 15 Schemes (4.8%)
Foreign Institutions
Held by 25 Foreign Institutions (3.18%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2025)
Net Profit:
-19 Million
Pharmaceuticals & Biotechnology
USD 54 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.00
-63.57%
0.42






